Showing results (161-170 of 2,991) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|November 23, 2022
Hereditary Angioedema: The Clinical Picture of Excessive Contact ActivationRemy S Petersen, Lauré M Fijen, Marcel Levi, et al.Seminars in Thrombosis and Hemostasis|July 1, 2022
Right Ventricular Recovery: Early and Late Changes after Acute PE DiagnosisAntoine Bejjani, Candrika D Khairani, Gregory PiazzaSeminars in Thrombosis and Hemostasis|June 21, 2021
Cardiovascular Oncology: The Need for a Multidisciplinary ApproachRodrigo Ortega Pérez, Ana Pardo Sanz, Valentín García Gutiérrez, et al.Seminars in Thrombosis and Hemostasis|July 13, 2021
Fibrin Network Porosity and Endo-/Exogenous Thrombin Cross-talkShu He, Håkan Wallén, Charlotte Thålin, et al.Seminars in Thrombosis and Hemostasis|July 13, 2021
The Growing Impact of Cardiovascular Oncology: Epidemiology and PathophysiologyAntonella Tufano, Antonio Coppola, Maurizio GalderisiSeminars in Thrombosis and Hemostasis|October 10, 2017
Platelet CLEC-2: Roles Beyond HemostasisKatsue Suzuki-Inoue, Nagaharu Tsukiji, Toshiaki Shirai, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Thromboembolic risks and complications in nephrotic childrenN SchlegelSeminars in Thrombosis and Hemostasis|January 1, 1997
Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty yearsW Zenz, F Arlt, S Sodia, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitorM J Hursting, K L Alford, J C Becker, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Development of argatroban, a direct thrombin inhibitor, and its clinical applicationT Matsuo, M Koide, K KarioPageof 300